The COPD patient journey is difficult
After diagnosis, patients may experience worsening symptoms, exacerbations, some of which lead to Emergency Department (ED) visits and hospitalisation. Untreated exacerbations can lead to permanent lung damage, oxygen therapy, and even death.
Current home monitoring misses early signals
Most Remote Patient Monitoring solutions rely on:
- Symptom questionnaires
- Pulse oximetry
- Sporadic clinical checks
These signals change when it’s already too late
By the time abnormalities are detected:
- The exacerbation is already ongoing
- The patient is heading to the ED
- The window for early intervention is lost
Impact and causes
The burden of poor COPD management impacts patient quality of life and the sustainability of our healthcare systems.
According to several scientific researches, the causes of such problems are mostly linked to access / logistics (35% of avoidable exacerbation) for example patients can’t get fast GP slots etc. and recognition / interpretation (25% of the avoidable exacerbation) for example some patients struggle to distinguish day-to-day fluctuation vs. true exacerbation; others recognise it but still wait for it to pass.
The global economic burden from 2020 to 2050 is projected to reach €3.7 trillion. Europe and Central Asia accounting for €605 billion (16%).
60%
ED visits for COPD exacerbations could be prevented
55%
Are due to delayed recognition of symptoms or healthcare access
€3.7Trillion
Global economic burden (2020–2050)
How COPD is managed in the real world
Different healthcare systems. Same outcome: avoidable emergency visits.
| Country | Main barrier | What happens in practice |
| Germany | The system is highly hospital-centric, with one of the highest numbers of beds per capita in Europe. The default response to breathing issues is rapid hospitalization rather than home-based escalation. | Patients often bypass primary care and go directly to clinics, knowing they will be admitted. This leads to over-treatment of mild exacerbations that could have been managed earlier with proper monitoring. |
| France | In many rural areas, access to pulmonologists is limited, and appointments can take weeks. | When symptoms worsen, GPs may lack the tools or confidence to adjust advanced therapies. With no rapid specialist access, the Emergency Department becomes the only fast entry point, often when the condition is already severe. |
| Netherlands | Care pathways are highly structured and protocol-driven, often focusing on COPD as a single condition. | Patients with multiple comorbidities struggle within rigid pathways, while self-management expectations can lead to patient fatigue and reduced adherence, delaying intervention until escalation is required. |
| Spain | Primary care plays a central role but is currently under significant pressure due to high patient volumes. | Limited consultation time reduces the ability to detect early worsening, leading to late intervention and increased reliance on emergency care. |
| United Kingdom | The NHS provides universal access but is facing backlogs, fragmentation, and workforce shortages. | Patients are often discharged without a comprehensive care plan, and follow-ups may be superficial. This leads to high readmission rates and repeated ED visits. |
| United States | The healthcare system offers advanced technology but is heavily influenced by cost and insurance structures. | Patients often reduce or skip treatment due to out-of-pocket costs, causing a gradual decline followed by sudden, severe exacerbations requiring emergency care. |
| Brazil | Access to long-term maintenance therapies is inconsistent, particularly in rural areas. | Patients rely on short-term relief medications without addressing underlying inflammation, leading to sudden clinical deterioration and emergency hospitalization. |
The opportunity: predict exacerbations earlier
Instead of reacting to worsening,
predict it before it happens. VoiceMed Predict uses vocal biomarkers to detect subtle physiological changes associated with respiratory deterioration.
A simple voice check becomes an early clinical signal.
API-first architecture
No hardware required
Scalable across large patient populations